Search clinical trials for: Modulation of FiO2

Total 10000 results

Daiichi Sankyo, Inc.

Completed

Cancer Venous Thromboembolism (VTE)

Cancer | Venous Thromboembolism (VTE) | Deep Vein Thrombosis (DVT) | Pulmonary Embolism (PE)

United States, Netherlands, Italy, Belgium, France, Hungary
National Cancer Institute (NCI)

Completed

Bortezomib and Lenalidomide in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma

Recurrent Mantle Cell Lymphoma

United States
Merck Sharp & Dohme LLC
Ariad Pharmaceuticals

Completed

Trial of Deforolimus in Combination With Bevacizumab for Patients With Advanced Cancers (8669-010)(COMPLETED)

Solid Tumor
Santen Inc.
MacuSight, Inc.

Terminated

Phase 2 Study of an Ocular Sirolimus (Rapamycin) Formulation in Combination With Lucentis® in Patients With Age-Related Macular Degeneration (EMERALD)

Age-Related Macular Degeneration | Choroidal Neovascularization

United States
National Cancer Institute (NCI)

Completed

Phase II Trial of Peginterferon Alpha-2b and Thalidomide in Adults With Recurrent Gliomas

Glioma

United States
University Hospitals Cleveland Medical Center

Completed

Improving Care for Women With Urinary Incontinence (EMPOWER)

Urinary Incontinence

United States
Columbia University
Mayo Clinic; University of California, Los Angeles; University of Maryland; University... and other collaborators

Active, not recruiting

Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial - Hemodynamics (CREST-H) (CREST-H)

Cognitive Impairment | Internal Carotid Artery Stenosis

United States, Canada
Pamukkale University

Completed

Telerehabilitation-based Exercise Training in Constipated Patients

Constipation

Turkey (Türkiye)
Hellenic Society of Hematology
GlaxoSmithKline

Recruiting

A Study to Investigate the Safety and Clinical Activity of Belantamab Mafodotin in Combination With Daratumumab, Lenalidomide and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Transplant Ineligible

Neoplasms | Multiple Myeloma | Neoplasms, Plasma Cell | Paraproteinemias | Blood Protein Disorders | Corneal Disease | Gammopathy, Monoclonal | Haematologic Disease

Greece
University Hospital, Toulouse
Celgene; Onyx Therapeutics, Inc.

Completed

Front-line Therapy With Carfilzomib, Lenalidomide, and Dexamethasone Induction (IFM-CRd)

Multiple Myeloma

France
AbbVie

Active, not recruiting

A Study to Assess the Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma Receiving Oral ABBV-453 Tablets

Relapsed/Refractory Multiple Myeloma

United States, Australia, Israel, United Kingdom
Sanofi

Active, not recruiting

A Prospective, Non-interventional, Multinational, Observational Study With Isatuximab in Patients With Relapsed and/or Refractory Multiple Myeloma (RRMM) (IONA-MM)

Plasma Cell Myeloma

Japan, Taiwan, United States, Argentina, Austria, Belgium, China, France, Germany, Greece, Hong Kong, Italy, Kuwait, Netherlands, Puerto Rico, Russian Federation, Saudi Arabia, Spain, Switzerland, United Arab Emirates, United Kingdom
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

Lenalidomide and Obinutuzumab in Treating Patients With Relapsed Indolent Non-Hodgkin Lymphoma

Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Marginal Zone Lymphoma | Recurrent Small Lymphocytic Lymphoma | Refractory Small Lymphocytic Lymphoma | Recurrent Follicular Lymphoma | Refractory Follicular Lymphoma | Refractory... and other conditions

United States
Janssen Pharmaceutical K.K.

Completed

A Study of JNJ-54767414 (Daratumumab) in Combination With Lenalidomide and Dexamethasone in Japanese Participants With Previously Untreated Multiple Myeloma Who Are Ineligible for High-dose Therapy and Autologous Stem Cell Transplantation

Multiple Myeloma

Japan
OncoSec Medical Incorporated

Completed

Trial of pIL-12 Electroporation Malignant Melanoma (IL-12MEL)

Melanoma

United States
Amgen

Completed

Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma

Relapsed Multiple Myeloma

United States, Canada, United Kingdom, France, Belgium, Austria, Spain, Israel, Italy, Bulgaria, Czechia, Germany, Greece, Hungary, Netherlands, Poland, Romania, Russian Federation, Serbia, Sweden
Criterium, Inc.
Celgene Corporation; Amgen

Terminated

A Safety and Efficacy Study of Carfilzomib and Pomalidomide With Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma

Multiple Myeloma

United States
Rajaie Cardiovascular Medical and Research Center

Terminated

Catheter-Directed Thrombolysis Versus Anticoagulation Monotherapy in Intermediate-High Risk PE (CANARY)

Pulmonary Embolism | Right Ventricular Dysfunction | Embolism, Pulmonary | Pulmonary Thromboembolisms

Iran, Islamic Republic of
Northwestern University

Completed

Bevacizumab in Treating Patients With Recurrent or Progressive Meningiomas

Neurofibromatosis Type 1 | Neurofibromatosis Type 2 | Adult Ependymoma | Recurrent Adult Brain Tumor | Acoustic Schwannoma | Adult Anaplastic Meningioma | Adult Grade I Meningioma | Adult Grade II Meningioma | Adult Meningeal Hemangiopericytoma | Adult Papillary Meningioma

United States
Arman Mashayekhi
Allergan

Terminated

Dexamethasone Intravitreal Implant for Treatment of Macular Edema After Plaque Radiotherapy of Uveal Melanoma

Macular Edema | Uveal Melanoma | Radiation Retinopathy | Cystoid Macular Edema | Radiation Maculopathy

United States
Allergan

Completed

Safety and Efficacy Study of Dexamethasone Versus Ranibizumab in Patients With Diabetic Macular Edema

Macular Edema

France, Spain, Belgium, United States, South Africa, Denmark, Netherlands, Israel, Portugal, United Kingdom, Italy, Germany
Peng Liu
Chipscreen Biosciences, Ltd.

Unknown

Phase 2 Trial of Chidamide-Lenalidomide-Dexamethasone(CRD) Regimen in R/R MM

Multiple Myeloma

China
Medical University of South Carolina

Terminated

PEG-Interferon Alfa-2b, Sargramostim, and Thalidomide in Treating Patients With Metastatic Kidney Cancer

Kidney Cancer

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Terminated

Lenalidomide With or Without Rituximab in Treating Patients With Progressive or Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Prolymphocytic Leukemia, or Non-Hodgkin Lymphoma Previously Treated With Donor Stem Cell Transplant

Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma and other conditions

United States
Bristol-Myers Squibb
Exelixis

Completed

Multiple Ascending Dose (MAD) Combination in Subjects With Multiple Myeloma

Advanced Cancer, Various, NOS

United States
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Iodine I 131 Monoclonal Antibody 3F8 and Bevacizumab in Treating Patients With Relapsed or Refractory Neuroblastoma

Neuroblastoma

United States
University of British Columbia

Completed

Phase II Pilot Study of Visudyne® Photodynamic Therapy (PDT) (Low and Very Low Fluence) Combined With Bevacizumab.

Macular Degeneration

Canada
Pfizer

Completed

Evaluation of PD 0348292 for Preventing Blood Clots in the Lungs or Deep Leg Veins of Patients After Knee Surgery

Venous Thrombosis

Australia, United States, Spain, Czech Republic, Portugal, Canada, South Africa, Italy, Colombia, Poland, France, Chile, Russian Federation, Denmark, United Kingdom, Slovakia
Butler Hospital
National Center for Complementary and Integrative Health (NCCIH)

Recruiting

Mood and Thought Process Study (MAT Process)

Depression | Depressive Symptoms | Depression in Remission

United States
University of Zurich

Completed

Novel Parameters for the Prediction of Ventriculoperitoneal Shunting Efficacy in Patients With iNPH (iNPH)

Idiopathic Normal Pressure Hydrocephalus

Switzerland
Baylor College of Medicine
National Institute of Mental Health (NIMH); Brown University; University of Iowa and other collaborators

Completed

Targeting HIV Retention and Improved Viral Load Through Engagement ('THRIVE')

Depression | Anxiety | Human Immunodeficiency Virus

United States
Weill Medical College of Cornell University
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Reimagining Interventions for Support and Education in Hypersensitivity Pneumonitis (RISE-HP)

Hypersensitivity Pneumonitis

United States
University of Michigan
National Heart, Lung, and Blood Institute (NHLBI)

Active, not recruiting

Testing Responses of Young Adults to Intervention Messages for Promoting Physical Activity Trial (TRY AIM)

Weight Gain | Physical Inactivity

United States
Hangzhou Sumgen Biotech Co., Ltd.

Recruiting

A Clinical Study Comparing SG301 Plus Pomalidomide and Dexamethasone to Placebo Plus Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma Patients

Relapsed/Refractory Multiple Myeloma

China
Yongyong MA

Recruiting

Daratumumab/Daratumumab and Hyaluronidase-fihj in Combination With Pomalidomide and Dexamethasone for the Treatment of Patients With Newly Diagnosed AL Amyloidosis: a Prospective, Multicenter, Single-arm Study

Amyloid Light-chain Amyloidosis

China
Princess Maxima Center for Pediatric Oncology
UMC Utrecht; Dutch Cancer Society

Recruiting

Central Line-associated Bloodstream Infection Prevention Using TauroLock-Hep100 in Pediatric Oncology Patients. (CATERPILLAR)

Central Line-associated Bloodstream Infection (CLABSI)

Netherlands
Janssen Research & Development, LLC

Active, not recruiting

A Study of Ciltacabtagene Autoleucel and Talquetamab for the Treatment of Participants With High-Risk Multiple Myeloma (MonumenTAL-8)

Multiple Myeloma

United States, Australia
Jonsson Comprehensive Cancer Center

Active, not recruiting

Psychoeducation for Uveal Melanoma

Uveal Melanoma

United States
Bayer

Completed

Observational Studies in Cancer Associated Thrombosis for Rivaroxaban - United States Cohort (OSCAR-US)

Treatment of Venous Thromboembolism in Cancer Patients | Prophylaxis of Recurrent Venous Thromboembolism in Cancer Patients

United States
Bristol-Myers Squibb

No longer available

Expanded Access Treatment Protocol CA204-143

Multiple Myeloma

United States
AbbVie
Celgene

Terminated

A Study of Venetoclax in Combination With Pomalidomide and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma

Multiple Myeloma

United States, Spain, United Kingdom
Lions Eye Institute, Perth, Western Australia
Allergan; Lions Outback Vision

Completed

Intravitreal Dexamethasone vs Bevacizumab in Aboriginal People With DMO (OASIS)

Diabetic Retinopathy | Diabetic Macular Edema

Australia
Amgen

Completed

Phase 1b Study of Weekly Carfilzomib in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma

Multiple Myeloma

United States
Cancer Trials Ireland

Completed

Study of the Efficacy and Safety of RsqVD Combination Therapy for Patients With Newly Diagnosed Multiple Myeloma

Multiple Myeloma

Ireland
Grupo Español de Linfomas y Transplante Autólogo...
Celgene Corporation; Dynamic Science S.L.; Thermo Fisher Scientific, Inc

Completed

Clinical Trial to Determinate Dose, Security and Efficacy or Lenalidomide and Rituximab (LR)-ESHAP in Patients With Diffuse Large B-cell Lymphoma

Diffuse Large B-cell Lymphoma

Spain
Celgene

Completed

Efficacy and Safety Study of 3 Thalidomide Doses for the Treatment of Relapsed Refractory Multiple Myeloma (OPTIMUM)

Multiple Myeloma

India, Philippines, France, Portugal, Poland, South Africa, Bulgaria, Croatia, Czechia, Germany, Hungary, Italy, Serbia, Slovakia, United Kingdom
Daiichi Sankyo, Inc.

Completed

A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis (eTRIS)

Venous Thrombosis | Deep Vein Thrombosis

United States, Canada
University of Arkansas

Withdrawn

2017-03: A Single-Arm, Open-label Study of Anti-Signaling Lymphocytic Activation Molecule F7 (Anti-SLAMF7) Monoclonal Antibody (mAb) Therapy After Autologous Stem Cell Transplant in Patients With Multiple Myeloma

Multiple Myeloma

United States
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Completed

Effect of Bevacizumab on Radiation-induced Brain Necrosis in Patients With Nasopharyngeal Carcinoma (BRAIN)

Nasopharyngeal Carcinoma | Adverse Effect of Radiation Therapy | Brain Necrosis

China
Jaeb Center for Health Research
National Eye Institute (NEI); Genentech, Inc.; Allergan

Completed

Phase II Combination Steroid and Anti-VEGF for Persistent DME

Diabetic Macular Edema

United States

Search clinical trials for: Modulation of FiO2

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Romania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations